{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:39Z","timestamp":1787020239737,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["94-03-30- 29952"],"award-info":[{"award-number":["94-03-30- 29952"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Skin cancer is the most common cancer worldwide and commonly classified into malignant melanoma (MM) and Nonmelanoma skin cancers (NMSCs), which mainly include basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The extent to which Long Interspersed Element-1 (LINE-1, L1) ORF1p is expressed in cutaneous malignancies remains to be evaluated. This study aimed to assess LINE-1 ORF1p immunoreactivity in various skin cancer subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The expression level of LINE-1 ORF1p was evaluated in 95 skin cancer specimens comprising 36 (37.9%) BCC, 28 (29.5%) SCC, and 31 (32.6%) melanoma using the tissue microarray (TMA) technique. Then the association between expression of LINE-1 encoded protein and clinicopathological parameters was analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We showed that LINE-1 ORF1p expression level was substantially higher in BCC and SCC patients compared with melanoma samples (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). BCC cases had a higher LINE-1 histochemical score (H-score) compared with SCC cases (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). In SCC samples, a lower level of LINE-1 ORF1p expression was associated with age younger than the mean (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.041). At the same time, no significant correlation was found between LINE-1 ORF1p expression and other clinicopathological parameters (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>According to our observation, LINE-1 ORF1p immunoreactivity in various skin tumor subtypes extends previous studies of LINE-1 expression in different cancers. LINE-1ORF1p overexpression in NMSCs compared with MM can be considered with caution as a tumor-specific antigen for NMSCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07050-6","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T08:02:58Z","timestamp":1592380978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies"],"prefix":"10.1186","volume":"20","author":[{"given":"Mohammad Ali","family":"Zolfaghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-8502","authenticated-orcid":false,"given":"Abbas","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Korourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ghanadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Kamyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Esmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Nader","family":"Emami Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Madjd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"issue":"3","key":"7050_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","volume":"29","author":"R Gordon","year":"2013","unstructured":"Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013;29(3):160\u20139.","journal-title":"Semin Oncol Nurs"},{"issue":"4","key":"7050_CR2","first-page":"82","volume":"5","author":"A Fahradyan","year":"2017","unstructured":"Fahradyan A, Howell AC, Wolfswinkel EM, Tsuha M, Sheth P, Wong AK. Updates on the Management of Non-Melanoma Skin Cancer (NMSC). Healthcare (Basel, Switzerland). 2017;5(4):82.","journal-title":"Healthcare (Basel, Switzerland)"},{"issue":"2","key":"7050_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0702a01","volume":"7","author":"Z Apalla","year":"2017","unstructured":"Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1\u20136.","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"7050_CR4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4065\/81.4.500","volume":"81","author":"DL Cummins","year":"2006","unstructured":"Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A. Cutaneous malignant melanoma. Mayo Clin Proc. 2006;81(4):500\u20137.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"7050_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bjo.2006.105676","volume":"91","author":"JA Nerad","year":"2007","unstructured":"Nerad JA. All skin cancers are not created equal. Br J Ophthalmol. 2007;91(3):276\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7050_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3322\/caac.20074","volume":"60","author":"DS Rigel","year":"2010","unstructured":"Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin. 2010;60(5):301\u201316.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"7050_CR7","doi-asserted-by":"crossref","first-page":"37e","DOI":"10.1097\/PRS.0b013e318206352b","volume":"127","author":"DT Netscher","year":"2011","unstructured":"Netscher DT, Leong M, Orengo I, Yang D, Berg C, Krishnan B. Cutaneous malignancies: melanoma and non-melanoma types. Plast Reconstr Surg. 2011;127(3):37e\u201356e.","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"7050_CR8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/cancers2041980","volume":"2","author":"G Fabbrocini","year":"2010","unstructured":"Fabbrocini G, Triassi M, Mauriello MC, Torre G, Annunziata MC, De Vita V, Pastore F, D'Arco V, Monfrecola G. Epidemiology of skin cancer: role of some environmental factors. Cancers. 2010;2(4):1980\u20139.","journal-title":"Cancers"},{"issue":"6","key":"7050_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/em.21859","volume":"55","author":"WK Kaufmann","year":"2014","unstructured":"Kaufmann WK, Carson CC, Omolo B, Filgo AJ, Sambade MJ, Simpson DA, Shields JM, Ibrahim JG, Thomas NE. Mechanisms of chromosomal instability in melanoma. Environ Mol Mutagen. 2014;55(6):457\u201371.","journal-title":"Environ Mol Mutagen"},{"issue":"10","key":"7050_CR10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrg2640","volume":"10","author":"R Cordaux","year":"2009","unstructured":"Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet. 2009;10(10):691\u2013703.","journal-title":"Nat Rev Genet"},{"issue":"6822","key":"7050_CR11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860\u2013921.","journal-title":"Nature"},{"issue":"1","key":"7050_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-012-2246-7","volume":"136","author":"L Chen","year":"2012","unstructured":"Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Res Treat. 2012;136(1):129\u201342.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"7050_CR13","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1093\/nar\/gkx211","volume":"45","author":"M Sokolowski","year":"2017","unstructured":"Sokolowski M, Chynces M, deHaro D, Christian CM, Belancio VP. Truncated ORF1 proteins can suppress LINE-1 retrotransposition in trans. Nucleic Acids Res. 2017;45(9):5294\u2013308.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"7050_CR14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1373\/clinchem.2016.257444","volume":"63","author":"D Ardeljan","year":"2017","unstructured":"Ardeljan D, Taylor MS, Ting DT, Burns KH. The human long interspersed Element-1 Retrotransposon: an emerging biomarker of Neoplasia. Clin Chem. 2017;63(4):816\u201322.","journal-title":"Clin Chem"},{"issue":"2","key":"7050_CR15","first-page":"117","volume":"155","author":"J Gong","year":"2018","unstructured":"Gong J, Zhang Q, Wang Q, Ma Y, Du J, Zhang Y, Zhao X. Identification and verification of potential piRNAs from domesticated yak testis. Reproduction (Cambridge, England). 2018;155(2):117\u201327.","journal-title":"Reproduction (Cambridge, England)"},{"key":"7050_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2018.11.018","volume":"488","author":"MA Kerachian","year":"2019","unstructured":"Kerachian MA, Kerachian M. Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer. Clin Chim Acta. 2019;488:209\u201314.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"7050_CR17","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ajpath.2014.01.007","volume":"184","author":"N Rodic","year":"2014","unstructured":"Rodic N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol. 2014;184(5):1280\u20136.","journal-title":"Am J Pathol"},{"issue":"1","key":"7050_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.23849","volume":"124","author":"A Daskalos","year":"2009","unstructured":"Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field JK, Liloglou T. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer. 2009;124(1):81\u20137.","journal-title":"Int J Cancer"},{"issue":"8","key":"7050_CR19","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/1078-0432.CCR-09-2819","volume":"16","author":"K Saito","year":"2010","unstructured":"Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin Cancer Res. 2010;16(8):2418\u201326.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"7050_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018884","volume":"6","author":"E Sunami","year":"2011","unstructured":"Sunami E, de Maat M, Vu A, Turner RR, Hoon DS. LINE-1 hypomethylation during primary colon cancer progression. PLoS One. 2011;6(4):e18884.","journal-title":"PLoS One"},{"issue":"3","key":"7050_CR21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10549-012-2038-0","volume":"134","author":"AQ van Hoesel","year":"2012","unstructured":"van Hoesel AQ, van de Velde CJ, Kuppen PJ, Liefers GJ, Putter H, Sato Y, Elashoff DA, Turner RR, Shamonki JM, de Kruijf EM, et al. Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study. Breast Cancer Res Treat. 2012;134(3):1103\u201314.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"7050_CR22","volume":"9","author":"SY Park","year":"2014","unstructured":"Park SY, Seo AN, Jung HY, Gwak JM, Jung N, Cho NY, Kang GH. Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer. PLoS One. 2014;9(6):e100429.","journal-title":"PLoS One"},{"issue":"4","key":"7050_CR23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/jim-2016-000066","volume":"64","author":"DT Pramio","year":"2016","unstructured":"Pramio DT, Pennacchi PC, Maria-Engler SS, Campos AH, Duprat JP, Carraro DM, Krepischi AC. LINE-1 hypomethylation and mutational status in cutaneous melanomas. J Investig Med. 2016;64(4):899\u2013904.","journal-title":"J Investig Med"},{"issue":"5","key":"7050_CR24","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cell.2013.10.021","volume":"155","author":"MS Taylor","year":"2013","unstructured":"Taylor MS, LaCava J, Mita P, Molloy KR, Huang CR, Li D, Adney EM, Jiang H, Burns KH, Chait BT, et al. Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition. Cell. 2013;155(5):1034\u201348.","journal-title":"Cell"},{"issue":"5","key":"7050_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010770","volume":"5","author":"O Kabbarah","year":"2010","unstructured":"Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, Scott KL, Kwong LN, Xiao Y, Cordon-Cardo C, et al. Integrative genome comparison of primary and metastatic melanomas. PLoS One. 2010;5(5):e10770.","journal-title":"PLoS One"},{"issue":"6","key":"7050_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccr.2005.11.008","volume":"8","author":"O Kabbarah","year":"2005","unstructured":"Kabbarah O, Chin L. Revealing the genomic heterogeneity of melanoma. Cancer Cell. 2005;8(6):439\u201341.","journal-title":"Cancer Cell"},{"issue":"7","key":"7050_CR27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844\u20137.","journal-title":"Nat Med"},{"key":"7050_CR28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2144\/04361RV01","volume":"36","author":"MM Ronald Simon","year":"2004","unstructured":"Ronald Simon MM. And Guido Sauter: tissue microarrays. BioTechniques. 2004;36:98\u2013105.","journal-title":"BioTechniques"},{"issue":"19","key":"7050_CR29","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.7314\/APJCP.2014.15.19.8161","volume":"15","author":"MN Sabet","year":"2014","unstructured":"Sabet MN, Rakhshan A, Erfani E, Madjd Z. Co-expression of putative cancer stem cell markers, CD133 and nestin, in skin tumors. Asian Pac J Cancer Prev. 2014;15(19):8161\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"7050_CR30","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.5301\/jbm.5000165","volume":"31","author":"E Erfani","year":"2016","unstructured":"Erfani E, Roudi R, Rakhshan A, Sabet MN, Shariftabrizi A, Madjd Z. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes. Int J Biol Markers. 2016;31(1):e53\u201361.","journal-title":"Int J Biol Markers"},{"issue":"36","key":"7050_CR31","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u2013206.","journal-title":"J Clin Oncol"},{"issue":"6","key":"7050_CR32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.7.6.13766","volume":"7","author":"SL Martin","year":"2010","unstructured":"Martin SL. Nucleic acid chaperone properties of ORF1p from the non-LTR retrotransposon, LINE-1. RNA Biol. 2010;7(6):706\u201311.","journal-title":"RNA Biol"},{"issue":"1","key":"7050_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.toxlet.2014.05.025","volume":"229","author":"A Karimi","year":"2014","unstructured":"Karimi A, Madjd Z, Habibi L, Akrami SM. Exposure of hepatocellular carcinoma cells to low-level as (2) O (3) causes an extra toxicity pathway via L1 retrotransposition induction. Toxicol Lett. 2014;229(1):111\u20137.","journal-title":"Toxicol Lett"},{"issue":"1","key":"7050_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12011-014-0015-7","volume":"160","author":"A Karimi","year":"2014","unstructured":"Karimi A, Madjd Z, Habibi L, Akrami SM. Evaluating the extent of LINE-1 mobility following exposure to heavy metals in HepG2 cells. Biol Trace Elem Res. 2014;160(1):143\u201351.","journal-title":"Biol Trace Elem Res"},{"issue":"1\u20132","key":"7050_CR35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mrgentox.2012.07.004","volume":"749","author":"B Del Re","year":"2012","unstructured":"Del Re B, Marcantonio P, Gavoci E, Bersani F, Giorgi G. Assessing LINE-1 retrotransposition activity in neuroblastoma cells exposed to extremely low-frequency pulsed magnetic fields. Mutat Res. 2012;749(1\u20132):76\u201381.","journal-title":"Mutat Res"},{"issue":"6","key":"7050_CR36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/jid.2012.36","volume":"132","author":"S Hoshimoto","year":"2012","unstructured":"Hoshimoto S, Kuo CT, Chong KK, Takeshima TL, Takei Y, Li MW, Huang SK, Sim MS, Morton DL, Hoon DS. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Investig Dermatol. 2012;132(6):1689\u201397.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"7050_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1947601909360812","volume":"1","author":"CR Harris","year":"2010","unstructured":"Harris CR, Normart R, Yang Q, Stevenson E, Haffty BG, Ganesan S, Cordon-Cardo C, Levine AJ, Tang LH. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer. 2010;1(2):115\u201324.","journal-title":"Genes Cancer"},{"issue":"35","key":"7050_CR38","doi-asserted-by":"crossref","first-page":"E4894","DOI":"10.1073\/pnas.1502474112","volume":"112","author":"TT Doucet-O'Hare","year":"2015","unstructured":"Doucet-O'Hare TT, Rodic N, Sharma R, Darbari I, Abril G, Choi JA, Young Ahn J, Cheng Y, Anders RA, Burns KH, et al. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma. Proc Natl Acad Sci U S A. 2015;112(35):E4894\u2013900.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:13:52Z","timestamp":1623870832000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7050"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07050-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13181\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13181\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"3 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was performed in accordance with the 1975 Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. All experiments are approved by the Tehran University of Medical Sciences Research Ethics Committee in Iran (Ref no: IR.TUMS.REC.1394.1570).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest to disclose regarding funding from industrial sources or other disclosures concerning this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"567"}}